Quest Diagnostics Incorporated (DGX)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 144.17 |
| Open | 144.29 |
| Bid | 0.00 x 900 |
| Ask | 144.74 x 800 |
| Day's Range | 142.72 - 144.50 |
| 52 Week Range | 119.59 - 145.62 |
| Volume | |
| Avg. Volume | 959,388 |
| Market Cap | 15.924B |
| Beta (5Y Monthly) | 0.87 |
| PE Ratio (TTM) | 19.29 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.00 (2.09%) |
| Ex-Dividend Date | Jul 08, 2024 |
| 1y Target Est | N/A |
- Fortune
Employees are cheating on workplace drug tests at record rates—and legalized cannabis could be to blame
A rise in the use of recreational marijuana use in states that have legalized cannabis appears to be behind a spike in falsified workplace drug tests.
- Zacks
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
- Zacks
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
© 2024 Yahoo. All rights reserved.